Henry E. Pelish - 09 Jul 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role: Chief Scientific Officer
Signature: /s/ Nathan McConarty, attorney-in-fact
Issuer symbol: NUVL
Transactions as of: 09 Jul 2024
Net transactions value: $0
Form type: 4
Filing time: 11 Jul 2024, 16:50:02 UTC
Next filing: 27 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVL	Class A Common Stock	Award	$0	+13,100	+21%	$0.000000	76,595	09 Jul 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVL	Stock Option (Right to Buy)	Award	$0	+18,600		$0.000000	18,600	09 Jul 2024	Class A Common Stock	18,600	$73.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following July 9, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F2	The shares underlying this option vest over the four years following July 9, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.